Overview

Study to Assess the Longterm Safety of Sildenafil Citrate in Patients With Pulmonary Arterial Hypertension

Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
0
Participant gender:
All
Summary
Open label extension study to the pivotal efficacy study to assess the safety of sildenafil citrate in patients with pulmonary arterial hypertension
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Citric Acid
Sildenafil Citrate
Criteria
Inclusion Criteria:

- Patients with PAH who had completed the 12 week pivotal study

Exclusion Criteria:

- Any other patients with PAH that had not been included into the pivotal study